18 results on '"Russcher, Anne"'
Search Results
2. Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic
- Author
-
Russcher, Anne, van Boven, Michiel, Benincà, Elisa, Verweij, E. J. T. (Joanne), Molenaar-de Backer, Marijke W. A., Zaaijer, Hans L., Vossen, Ann C. T. M., and Kroes, Aloys C. M.
- Published
- 2024
- Full Text
- View/download PDF
3. Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person
- Author
-
Munnink, Bas B. Oude, Nijhuis, Roel H.T., Worp, Nathalie, Boter, Marjan, Weller, Babette, Verstrepen, Babs E., GeurtsvanKessel, Corine, Corsten, Maarten L., Russcher, Anne, and Koopmans, Marion
- Subjects
Immunocompromised host -- Case studies ,Health - Abstract
Persons with an immune deficiency can be infected with viral pathogens for a prolonged period. This occurrence has been reported for noroviruses (1) but also has been documented for SARS-CoV-2 [...]
- Published
- 2022
- Full Text
- View/download PDF
4. Diagnosis of intrauterine parvovirus B19 infection at birth – Value of DNA detection in neonatal blood and dried blood spots
- Author
-
Russcher, Anne, Enders, Anja, de Brouwer, Caroline S., Oepkes, Dick, Hahn, Ralph, Enders, Martin, Kroes, Aloys C.M., and Vossen, Ann C.T.M.
- Published
- 2020
- Full Text
- View/download PDF
5. Transient Parvovirus B19 DNAemia After Kidney Transplantation: A 2-Sided Story.
- Author
-
Russcher, Anne, Backer, Marijke Molenaar-de, Brouwer, Caroline de, Dijkstra, Kyra, Kers, Jesper, Vries, Aiko de, Zaaijer, Hans, Vossen, Ann, and Kroes, Aloysius
- Abstract
Parvovirus B19 (B19V) DNAemia appears to be a relatively common finding after kidney transplantation. However, not all DNAemia signifies active infection with replicating virus. This study screened 134 patients posttransplantation for B19V DNAemia and identified 2 cases in which viral DNA was present after transplantation, with the donor kidney as probable source of the DNA. In both cases intact viral particles could not be detected using an endonuclease method, indicating the presence of noninfectious DNA remnants. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Extreme upsurge of parvovirus B19 resulting in severe fetal morbidity and mortality
- Author
-
Russcher, Anne, Verweij, EJT (Joanne), Maurice, Paul, Jouannic, Jean-Marie, Benachi, Alexandra, Vivanti, Alexandre J, and Devlieger, Roland
- Published
- 2024
- Full Text
- View/download PDF
7. Evaluation of the Atellica® UAS 800: a new member of the automated urine sediment analyzer family.
- Author
-
Aper, Stijn J. A., Gijzen, Karlijn, Luimstra, Jolien J., van der Valk, Johanna T. M. H., Russcher, Anne, Koçer, Rüya G., Liesting, Eline C., Jacobs, Leo H. J., Lentjes, Eef G. W. M., and Demir, Ayşe Y.
- Subjects
CLINICAL biochemistry ,CLINICAL medicine ,CHEMICAL laboratories ,SPECTROPHOTOMETRY ,TRACE element analysis - Abstract
In 2017 the Atellica
® UAS 800 urine sediment analyzer was introduced by Siemens Healthineers. We investigated its applicability in the standardization and automation of the laboratory urinalysis workflow, including the prediction of urine culture outcome and glomerular pathology. We evaluated the performance characteristics of the Atellica® UAS 800 and its correlation with the iQ200 (Beckman Coulter). In addition, we studied the agreement between Atellica® UAS 800 and CLINITEK Novus® and determined the predictive value of bacteria and leukocyte counts for urine culture outcome. Furthermore, we investigated the ability of Atellica® UAS 800 to identify pathological casts and dysmorphic erythrocytes in comparison to manual microscopy. Erythrocyte and leukocyte analyses indicated high intra- and inter-run precisions and good correlations with the iQ200. We found that the Atellica® UAS 800 detects bacteria with higher sensitivity than the iQ200. The Atellica® UAS 800 and CLINITEK Novus® showed a high degree of conformity. We determined seven combinations of clinical cut-off values of bacteria and leukocytes for predicting urine culture outcome with sensitivity, specificity, and negative predictive values of 95%, 52%, and 93%, respectively. Using the Atellica® UAS 800, hyaline casts, erythrocyte casts, leukocyte casts, and dysmorphic erythrocytes were correctly recognized in 76%, 22%, 2%, and 39% of the samples, respectively. The Atellica® UAS 800 is a robust, fast, and user-friendly analyzer, which accurately quantifies erythrocytes, leukocytes, bacteria and squamous epithelial cells, and may be utilized for predicting positive urine cultures. The detection of clinically important pathological casts and dysmorphic erythrocytes proved insufficient. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
8. Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood.
- Author
-
Russcher, Anne, Verdonschot, Job, Molenaar‐de Backer, Marijke W.A., Heymans, Stephane R.B., Kroes, Aloys C.M., and Zaaijer, Hans L.
- Subjects
PARVOVIRUS B19 ,DILATED cardiomyopathy ,ENDONUCLEASES - Abstract
Aims: Parvovirus B19 (B19V) is often assumed to be a cause of dilated cardiomyopathy (DCM), based on the quantification of B19V DNA in endomyocardial biopsies (EMB). Whether the presence of B19V DNA correlates with active infection is still debated. Application of the enzyme endonuclease to blood samples results in degradation of B19V DNA remnants but leaves viral particles intact, which enables differentiation between active and past infection. In this study, the susceptibility to degradation by endonuclease of B19V DNA in blood was compared between DCM patients and a control group of recent B19V infections. Methods and results: Twenty blood samples from 20 adult patients with DCM, who previously tested positive for B19V DNA in EMB and/or blood, were tested with B19V PCR before and after application of endonuclease to the samples. Six blood samples tested positive for B19V DNA with a mean viral load of 2.3 × 104 IU/mL. In five samples, B19V DNA became undetectable after endonuclease (100% load reduction); in one sample DNA load showed a 23% log load reduction (viral load before endonuclease: 9.1 × 104 IU/mL; after: 6.5 × 103 IU/mL). Presence of cardiac inflammation did not differ between patients with B19V DNAemia (1/4) and patients without B19V DNAemia (6/14) (P value = 1.0). In all 18 control samples of proven recent B19V infections, DNA remained detectable after application of endonuclease, showing only a mean log load reduction of 2.3% (mean viral load before endonuclease: 8.1 × 1011 IU/mL; after: 8.0 × 1011 IU/mL). Load reduction differed significantly between the DCM group and the control group; indicating the presence of intact viral particles in the control group with proven active infection and the presence of DNA remnants in the DCM group (P value = 0.000). Conclusion: During recent B19V infection, viral DNA levels in blood were unaffected by endonuclease. In contrast, B19V DNA in blood in patients with DCM became undetectable or strongly reduced after application of endonuclease. Circulating viral DNA in this subset of patients with presumed parvovirus‐associated DCM does not consist of intact viral particles. Viral replicative activity cannot be assumed from demonstrating B19V DNA in cardiac tissue or in blood in DCM patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Necrotising fasciitis as atypical presentation of infection with emerging Neisseria meningitidis serogroup W (MenW) clonal complex 11, the Netherlands, March 2017
- Author
-
Russcher, Anne, Fanoy, Ewout, van Olden, Ger D J, Graafland, Antonie D, van der Ende, Arie, and Knol, Mirjam J
- Subjects
Meningococcal Infections ,Treatment Outcome ,Debridement ,Fever ,Neisseria meningitidis, Serogroup W-135 ,Clindamycin ,Sepsis ,Humans ,Penicillin G ,Fasciitis, Necrotizing ,Meningitis, Meningococcal ,Serogroup ,Anti-Bacterial Agents - Abstract
In March 2017, a patient with necrotising fasciitis caused by Neisseria meningitidis serogroup W (MenW) clonal complex 11 was diagnosed in the Netherlands. Unusual and severe presentations of MenW infections are common in the current European epidemic. In the Netherlands, the incidence of MenW infections increased 10-fold, from an average of 0.03 per 100,000 population in 2002-2014 to 0.29 in 2016. Awareness of atypical presentations enables timely adequate treatment and public health action.
- Published
- 2018
10. Capillary-Electrophoresis Mass Spectrometry for the Detection of Carbapenemases in (Multi-) Drug-Resistant Gram-Negative Bacteria.
- Author
-
Fleurbaaij, Frank, Heemskerk, Anthonius A. M., Russcher, Anne, Klychnikov, Oleg I., Deelder, André M., Mayboroda, Oleg A., Kuijper, Ed J., van Leeuwen, Hans C., and Hensbergen, Paul J.
- Published
- 2014
- Full Text
- View/download PDF
11. Longitudinal Monitoring of DNA Viral Loads in Transplant Patients Using Quantitative Metagenomic Next-Generation Sequencing.
- Author
-
Carbo, Ellen C., Russcher, Anne, Kraakman, Margriet E. M., de Brouwer, Caroline S., Sidorov, Igor A., Feltkamp, Mariet C. W., Kroes, Aloys C. M., Claas, Eric C. J., and de Vries, Jutte J. C.
- Subjects
EPSTEIN-Barr virus ,VIRAL load ,NUCLEOTIDE sequencing ,VIRAL DNA ,DNA virus diseases ,METAGENOMICS - Abstract
Introduction: Immunocompromised patients are prone to reactivations and (re-)infections of multiple DNA viruses. Viral load monitoring by single-target quantitative PCRs (qPCR) is the current cornerstone for virus quantification. In this study, a metagenomic next-generation sequencing (mNGS) approach was used for the identification and load monitoring of transplantation-related DNA viruses. Methods: Longitudinal plasma samples from six patients that were qPCR-positive for cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK polyomavirus (BKV), adenovirus (ADV), parvovirus B19 (B19V), and torque teno-virus (TTV) were sequenced using the quantitative metagenomic Galileo Viral Panel Solution (Arc Bio, LLC, Cambridge, MA, USA) reagents and bioinformatics pipeline combination. Qualitative and quantitative performance was analysed with a focus on viral load ranges relevant for clinical decision making. Results: All pathogens identified by qPCR were also identified by mNGS. BKV, CMV, and HHV6B were additionally detected by mNGS, and could be confirmed by qPCR or auxiliary bioinformatic analysis. Viral loads determined by mNGS correlated with the qPCR results, with inter-method differences in viral load per virus ranging from 0.19 log
10 IU/mL for EBV to 0.90 log10 copies/mL for ADV. TTV, analysed by mNGS in a semi-quantitative way, demonstrated a mean difference of 3.0 log10 copies/mL. Trends over time in viral load determined by mNGS and qPCR were comparable, and clinical thresholds for initiation of treatment were equally identified by mNGS. Conclusions: The Galileo Viral Panel for quantitative mNGS performed comparably to qPCR concerning detection and viral load determination, within clinically relevant ranges of patient management algorithms. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
12. 'FOR A BROKEN LIMB': FRACTURE TREATMENT IN ANGLO-SAXON ENGLAND.
- Author
-
Russcher, Anne and Bremmer Jr., Rolf H.
- Subjects
ANGLO-Saxon civilization ,MEDIEVAL medicine ,TREATMENT of fractures ,OLD English manuscripts ,MEDIEVAL learning & scholarship ,ARCHAEOLOGICAL finds ,BRITISH civilization ,BRITISH history to 1066 - Abstract
The treatment of fractures is a relatively simple and logical procedure mastered by many cultures worldwide, so it seems likely prima facie that the Anglo-Saxons would have had some means for treating such injuries as well. To investigate this matter, we shall first describe the modern standards of fracture treatment. Fractures can occur in any type or size of bone, but this paper will focus on long bone fractures, i.e., fractures of the arms and legs, since these were the most likely to be diagnosed correctly by Anglo-Saxon physicians, and hence most likely to received successful treatment. Then, after we describe common methods for treating these injuries in modern medicine, we will next turn to Anglo-Saxon medical literature and its classical sources. Finally, we shall analyse archaeological evidence of fractures in order to gauge the practice of treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
13. Evaluation of the Atellica ® UAS 800: a new member of the automated urine sediment analyzer family.
- Author
-
Aper SJA, Gijzen K, Luimstra JJ, van der Valk JTMH, Russcher A, Koçer RG, Liesting EC, Jacobs LHJ, Lentjes EGWM, and Demir AY
- Subjects
- Automation, Bacteria metabolism, Erythrocytes cytology, Humans, Leukocytes cytology, Logistic Models, ROC Curve, Sensitivity and Specificity, Urinalysis instrumentation
- Abstract
Background: In 2017 the Atellica
® UAS 800 urine sediment analyzer was introduced by Siemens Healthineers. We investigated its applicability in the standardization and automation of the laboratory urinalysis workflow, including the prediction of urine culture outcome and glomerular pathology., Methods: We evaluated the performance characteristics of the Atellica® UAS 800 and its correlation with the iQ200 (Beckman Coulter). In addition, we studied the agreement between Atellica® UAS 800 and CLINITEK Novus® and determined the predictive value of bacteria and leukocyte counts for urine culture outcome. Furthermore, we investigated the ability of Atellica® UAS 800 to identify pathological casts and dysmorphic erythrocytes in comparison to manual microscopy., Results: Erythrocyte and leukocyte analyses indicated high intra- and inter-run precisions and good correlations with the iQ200. We found that the Atellica® UAS 800 detects bacteria with higher sensitivity than the iQ200. The Atellica® UAS 800 and CLINITEK Novus® showed a high degree of conformity. We determined seven combinations of clinical cut-off values of bacteria and leukocytes for predicting urine culture outcome with sensitivity, specificity, and negative predictive values of 95%, 52%, and 93%, respectively. Using the Atellica® UAS 800, hyaline casts, erythrocyte casts, leukocyte casts, and dysmorphic erythrocytes were correctly recognized in 76%, 22%, 2%, and 39% of the samples, respectively., Conclusions: The Atellica® UAS 800 is a robust, fast, and user-friendly analyzer, which accurately quantifies erythrocytes, leukocytes, bacteria and squamous epithelial cells, and may be utilized for predicting positive urine cultures. The detection of clinically important pathological casts and dysmorphic erythrocytes proved insufficient.- Published
- 2021
- Full Text
- View/download PDF
14. Use of Automated Urine Microscopy Analysis in Clinical Diagnosis of Urinary Tract Infection: Defining an Optimal Diagnostic Score in an Academic Medical Center Population.
- Author
-
Foudraine DE, Bauer MP, Russcher A, Kusters E, Cobbaert CM, van der Beek MT, and Stalenhoef JE
- Subjects
- Academic Medical Centers, Adult, Aged, Bacteria growth & development, Bacteria isolation & purification, Female, Humans, Leukocyte Count, Leukocytes, Logistic Models, Male, Middle Aged, Retrospective Studies, Tertiary Care Centers, Urinary Tract Infections microbiology, Automation, Laboratory, Bacteriuria diagnosis, Microscopy methods, Urinalysis methods, Urinary Tract Infections diagnosis
- Abstract
A retrospective case record study was conducted that established a scoring tool based on clinical and iQ200 parameters, able to predict or rule out the clinical diagnosis of UTI in the majority of adult patients in an academic hospital. Automated standardized quantitative urine analysis, such as iQ200 analysis, is on the rise because of its high accuracy and efficiency compared to those of traditional urine analysis. Previous research on automated urinalysis focused mainly on predicting culture results but not on the clinical diagnosis of urinary tract infection (UTI). A retrospective analysis was conducted of consecutive urine samples sent in for culture because of suspected UTI. UTI was defined by expert opinion, based on reported symptoms, conventional urine sediment analysis, and urine cultures. Parameters of iQ200 analysis and clinical symptoms and signs were compared between cases and controls. Optimal cutoff values were determined for iQ200 parameters, and multivariate logistic regression analysis was used to identify the set of variables that best predicts the clinical diagnosis of UTI for development of a scoring tool. A total of 382 patients were included. Optimal cutoff values of iQ200 analysis were 74 white blood cells (WBC)/μl, 6,250 "all small particles" (ASP)/μl, and a bacterial score of 2 on an ordinal scale of 0 to 5. The scoring tool attributed 1 point for frequent micturition or increased urge, 2 points for dysuria, 1 point for a bacterial score of ≥2, 2 points for WBC/μl of ≥50, and an additional point for WBC/μl of ≥150. This score had a sensitivity of 86% and a specificity of 92% when using a threshold of <4 points. The combination of iQ200 analysis and a simple survey could predict or rule out UTIs in a majority of patients in an academic medical center., (Copyright © 2018 American Society for Microbiology.)
- Published
- 2018
- Full Text
- View/download PDF
15. Necrotising fasciitis as atypical presentation of infection with emerging Neisseria meningitidis serogroup W (MenW) clonal complex 11, the Netherlands, March 2017.
- Author
-
Russcher A, Fanoy E, van Olden GDJ, Graafland AD, van der Ende A, and Knol MJ
- Subjects
- Anti-Bacterial Agents therapeutic use, Clindamycin therapeutic use, Debridement, Fasciitis, Necrotizing therapy, Fever etiology, Humans, Meningitis, Meningococcal drug therapy, Meningitis, Meningococcal microbiology, Meningococcal Infections drug therapy, Meningococcal Infections microbiology, Penicillin G therapeutic use, Sepsis drug therapy, Sepsis microbiology, Serogroup, Treatment Outcome, Fasciitis, Necrotizing diagnosis, Meningitis, Meningococcal diagnosis, Meningococcal Infections diagnosis, Neisseria meningitidis, Serogroup W-135 isolation & purification
- Abstract
In March 2017, a patient with necrotising fasciitis caused by Neisseria meningitidis serogroup W (MenW) clonal complex 11 was diagnosed in the Netherlands. Unusual and severe presentations of MenW infections are common in the current European epidemic. In the Netherlands, the incidence of MenW infections increased 10-fold, from an average of 0.03 per 100,000 population in 2002-2014 to 0.29 in 2016. Awareness of atypical presentations enables timely adequate treatment and public health action., (This article is copyright of The Authors, 2017.)
- Published
- 2017
- Full Text
- View/download PDF
16. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013.
- Author
-
van Paassen J, Russcher A, In 't Veld-van Wingerden AW, Verweij PE, and Kuijper EJ
- Subjects
- Aspergillosis mortality, Aspergillus fumigatus classification, Aspergillus fumigatus genetics, Aspergillus fumigatus isolation & purification, Cytochrome P-450 Enzyme System, Drug Resistance, Fungal genetics, Fungal Proteins genetics, Genotype, Hospitals, University, Humans, Intensive Care Units, Microbial Sensitivity Tests, Netherlands epidemiology, Prognosis, Retrospective Studies, Treatment Outcome, Voriconazole therapeutic use, Antifungal Agents pharmacology, Aspergillosis drug therapy, Aspergillus fumigatus drug effects, Voriconazole pharmacology
- Abstract
The prevalence of invasive aspergillosis (IA) at the intensive care unit (ICU) is unknown and difficult to assess since IA also develops in patients lacking specific host factors. In the Netherlands, increasing azole-resistance in Aspergillus fumigatus complicates treatment of patients with IA. The aim of this study was to determine the prevalence of IA by azole-resistant A. fumigatus at the ICU among patients receiving antifungal treatment and to follow their clinical outcome and prognosis. A retrospective cohort study was conducted in a university hospital ICU from January 2010 to December 2013. From all patients who received antifungal treatment for suspected IA, relevant clinical and microbiological data were collected using a standardised questionnaire. Of 9,121 admitted ICU-patients, 136 had received antifungal treatment for suspected IA, of which 38 had a positive A. fumigatus culture. Ten of the 38 patients harboured at least one azole-resistant isolate. Resistance mechanisms consisted of alterations in the cyp51A gene, more specific TR34/L98H and TR46/T289A/Y121F. Microsatellite typing did not show clonal relatedness, though isolates from two patients were genetically related. The overall 90-day mortality of patients with IA by azole-resistant A. fumigatus and patients with suspicion of IA by azole-susceptible isolates in the ICU was 100% (10/10) vs 82% (23/28) respectively. We conclude that the changing pattern of IA in ICU patients requires appropriate criteria for recognition, diagnosis and rapid resistance tests. The increase in azole resistance rates also challenges a reconsideration of empirical antifungal therapy., (This article is copyright of The Authors, 2016.)
- Published
- 2016
- Full Text
- View/download PDF
17. Interlaboratory Collaboration for Optimized Screening for Urinary Tract Infection.
- Author
-
Russcher A, Kusters E, Wolterbeek R, Kuijper EJ, Cobbaert CM, and van der Beek MT
- Subjects
- Adult, Aged, Algorithms, Automation, Laboratory methods, Female, Hospitals, University, Humans, Male, Middle Aged, Predictive Value of Tests, Sensitivity and Specificity, Tertiary Care Centers, Urinalysis methods, Cooperative Behavior, Mass Screening methods, Urinary Tract Infections diagnosis
- Abstract
As the majority of urine samples submitted for culture yields a negative result, rapid screening that accurately predicts culture outcome benefits clinicians by reducing the time to result and improves the efficiency of the microbiological laboratory. Automated urinalysis using the IRIS Diagnostics iQ200 Elite (iQ200) analyzer permits just such a fast and large-scale screening. We aimed to predict and thus to reduce negative cultures with a screening algorithm based on iQ200 urinalysis in a tertiary university hospital. In parallel, we evaluated the performance of the iQ200 screen compared to that of Gram stain for sample quality. We screened 1,442 samples submitted for bacterial culture using the iQ200 analyzer; of these samples, 357 (24.8%) had a positive culture result. We identified the absence of microorganisms in the iQ200 screen as the strongest solitary predictor for a negative culture, with a sensitivity of 90.5% (323/357). The algorithm was further improved by performing logistic regression on leukocyte counts, which gave a cutoff of 65 leukocytes/μl to obtain the desired sensitivity of >95% (95.2%; 95% confidence interval [CI], 92.5 to 97.0), a negative predictive value of 97.3% (95% CI, 95.7 to 98.3), and an anticipated culture workload reduction of 44% (95% CI, 41 to 46). Concordance between sample quality based on Gram stain and iQ200 screening was only 72%, which was probably a result of interobserver effect in evaluation of the Gram stain. In conclusion, in our setting, screening by iQ200 proved to be a safe and cost-effective means to provide faster culture results, and it has the added benefit of a more objective evaluation of sample quality., (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Published
- 2016
- Full Text
- View/download PDF
18. Clinical impact of RT-PCR for pediatric acute respiratory infections: a controlled clinical trial.
- Author
-
Wishaupt JO, Russcher A, Smeets LC, Versteegh FG, and Hartwig NG
- Subjects
- Acute Disease, Antiviral Agents therapeutic use, Child, Preschool, Female, Follow-Up Studies, Humans, Infant, Linear Models, Male, Multivariate Analysis, Netherlands, Reference Values, Respiratory Syncytial Virus Infections drug therapy, Respiratory Tract Infections virology, Risk Assessment, Severity of Illness Index, Statistics, Nonparametric, Treatment Outcome, Real-Time Polymerase Chain Reaction, Respiratory Syncytial Virus Infections diagnosis, Respiratory Syncytial Viruses isolation & purification, Respiratory Tract Infections diagnosis, Respiratory Tract Infections drug therapy
- Abstract
Objective: Real-time polymerase chain reaction (RT-PCR) testing is a quick sensitive method for detecting respiratory pathogens. We evaluated the diagnostic yield of RT-PCR assays and measured the effect of rapid reporting on patient care., Methods: In a controlled clinical trial, nasal wash specimens were obtained from patients <12 years of age with suspected acute respiratory infections. In addition to the standard hospital protocol, RT-PCR assays for 17 pathogens were performed. The RT-PCR results were communicated to the clinicians within 12 to 36 hours in the intervention group and after 4 weeks in the control group., Results: A total of 583 patients were included (mean age: 8.1 months [range: 0-107.5 months]): 298 in the intervention group and 285 in the control group. Eighty-two percent of nasal wash specimens tested positive for ≥1 pathogen. Respiratory syncytial virus was the most frequently encountered (55%) pathogen. There were no significant differences between the groups with respect to hospital admissions (intervention group: 223 admissions; control group: 211 admissions; P = .825), length of hospital stay (mean ± SD: 3.68 ± 2.68 days [intervention group] and 3.96 ± 2.67 days [control group]; P = .178), or duration of antibiotic use (mean ± SD: 6.52 ± 2.15 days [intervention group] and 6.97 ± 2.86 days [control group]; P = .490), when antibiotic treatment had been initiated., Conclusions: RT-PCR testing has a high yield of viral diagnoses, but rapid communication does not lead to decreases in hospital admissions, shorter hospital stays, or less antibiotic use for children with acute respiratory infections.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.